Navigation Links
New cause of child blindness identified
Date:7/30/2012

This press release is available in French.

Montreal, July 29 2012 One of the mysteries of blindness has been solved. A team of international scientists in collaboration with the Research Institute of the McGill University Health Centre (RI MUHC) identified a new gene responsible for Leber Congenital Amaurosis (LCA), a devastating genetic form of blindness in newborns. What makes this discovery so exceptional is that this new gene called NMNAT1 known to be crucial for life has never been associated with any human disease. This is the first time such a major correlation has been established. The study was published today in the journal Nature Genetics.

"This is probably one of the most important discoveries in neuroscience and blindness in the past 15 years," said Dr. Robert Koenekoop, first author of the study, Director of the McGill Ocular Genetics Laboratory at the Montreal Children's Hospital of the MUHC and Associate Professor in Human Genetics and Ophthalmology in the Faculty of Medicine at McGill University. "Researchers have been looking for the link between NMNAT1 mutations and human disease in the brain or body for many years".

LCA is a rare, inherited eye disease that appears at birth or within the first few months of life, affecting about 1 in 80,000 newborns. Although there is no accepted treatment available for LCA, researchers have discovered 18 genes responsible for this particular form of blindness. To Dr. Koenekoop NMNAT1 is one of the most exciting genes of the 18 currently known genes to cause LCA because it opens up a whole new pathway of disease. "We can now identify the gene responsible for LCA in 75 per cent of children. We are getting closer to being able to identify all the genes for this form of child blindness and develop effective treatments," added the researcher

"Dr Koenekoop and his international colleagues have had tremendous success in uncovering and understanding the genetics of LCA," said Sharon Colle, President and CEO of the Foundation Fighting Blindness Canada. "We are proud to support him with the help of our generous donors. Identifying these mutations helps families struggling with this rare disease get a firm diagnosis, which is the first step towards potential treatments."

As with many scientific breakthroughs, establishing the connection between NMNAT1 and LCA challenged researchers to question long-held beliefs. Using cutting-edge genetic technology the team began by analyzing the entire genome of 60 infants with LCA. They excluded genes already known in order to maximize their chances of identifying new ones. "When we discovered the new gene was NMNAT1 we thought it was impossible, because - from bacteria to human - it plays such an important role in life that we believed if you had a mutation on NMNAT1 you would die," explained Dr. Koenekoop.

The gene NMNAT1 is found in every single cell in the human body. It produces a vital coenzyme called NAD, involved in hundreds of reactions in the cell. NMNAT1 is surprisingly also part of a rescue mechanism that slows down degeneration of neurons, and thus helps prevent the onset of many diseases such as Alzheimer's and Parkinson's disease.

"Our findings will have immediate therapeutic implications for blindness and may open the door to new treatments for other neurodegenerative diseases," added Dr. Rui Chen, senior author of the study and an Associate Professor at Baylor College of Medicine in Houston.

"Because higher levels of NAD have been shown to significantly delay degeneration of neurons, our team's work raises the exciting possibility that giving NAD as a drug in young LCA patients with NMNAT1 mutations may be a potential therapeutic option to cure blindness in the near future," concluded Dr. Koenekoop.


'/>"/>
Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-934-1934 x71381
McGill University Health Centre
Source:Eurekalert

Related biology news :

1. Massachusetts Eye and Ear researchers discover elusive gene that causes a form of blindness from birth
2. Sickle cell trait can cause sudden cardiac death in black athletes: Why is this controversial?
3. Study points to causes of high dolphin deaths in Gulf of Mexico
4. Poisoning from industrial compounds can cause similar effects to ALS
5. Hormone-mimicking chemicals cause inter-species mating
6. Zebrafish provide insights into causes and treatment of human diseases
7. Scientists discover an epigenetic cause of osteoarthritis
8. UCLA study looks at why heart attacks cause so much more damage in late pregnancy
9. Flu immunity is affected by how many viruses actually cause the infection
10. Gene mutations cause massive brain asymmetry
11. Double the pain: RUB biologists find the cause of pain in the treatment of fair skin cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market ... the next decade to reach approximately $14.21 billion by 2025. ... for all the given segments on global as well as regional ...
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
(Date:3/20/2017)... -- At this year,s CeBIT Chancellor Dr. Angela Merkel ... Chancellor came to the DERMALOG stand together with the Japanese Prime Minster ... country. At the largest German biometrics company the two government leaders could ... recognition as well as DERMALOG´s multi-biometrics system.   ... ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has ... has hosted corporate cooking challenges for companies around the world, such as Illumina, HP and ... of the reason for its increasing popularity is due to its new team building format, ...
(Date:3/23/2017)...  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a ... solid tumor cancers, today announced that yesterday it ... last Friday, March 17, 2017. ... totaling 28,843,692 shares, comprised of 18,843,692 common shares ... Class C Warrants pre-funded at the closing at ...
(Date:3/23/2017)... LOUISVILLE, Colo. , March 23, 2017  GlobeImmune, ... purchase agreement for the sale of 12,835,490 shares of ... the  NantWorks  ecosystem of companies. In connection with the sale ... GlobeImmune $100,000 in cash and issue to GlobeImmune 200,000 ... common stock. "We are pleased to ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... selected by the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® ... annual Women of Innovation Awards Dinner. , The dinner recognizes women accomplished in ...
Breaking Biology Technology: